Jenna Stein cofounded LabShares with Jeff Behrens in August of 2018 and served as the initial Director of Operations and Finance. She left LabShares in a full-time capacity at the end of 2019 to pursue opportunities in drug development, where her true passion lies. Prior to and overlapping with LabShares, Jenna spent just over five years at Siamab Therapeutics developing two therapeutic antibodies for the treatment of solid tumors; she managed operations, finance, and program and alliance management, and played a key role in the acquisition of the lead asset. Jenna received a BS in Biology from the University of Massachusetts Amherst and is finishing her MBA from the F.W. Olin Graduate School of Business at Babson College.